Skip to search formSkip to main contentSkip to account menu

milligram/day

Known as: mg/24h, mg day, Milligram per Day 
A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object… 
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in…
Aim  To compare the effects of combining liraglutide (0.6, 1.2 or 1.8 mg/day) or rosiglitazone 4 mg/day (all n ≥ 228) or placebo… 
Review
2004
Review
2004
Pregabalin relieves symptoms of painful diabetic neuropathy
Objective: Pregabalin, an alpha2-delta ligand with analgesic, anxiolytic, and anticonvulsant activity, has been evaluated for… 
Highly Cited
2003
Highly Cited
2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
OBJECTIVE To evaluate the course of glucocorticoid (GC) therapy and associated adverse events in a population-based cohort of… 
Highly Cited
2002
Highly Cited
2002
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.
Thalidomide (Thal) can overcome drug resistance in multiple myeloma (MM) but is associated with somnolence, constipation, and… 
Highly Cited
2001
Highly Cited
2001
A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS
Background. Despite the various immunosuppressive regimens presently in use, acute rejection in the early postoperative period… 
Highly Cited
2000
Highly Cited
2000
Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
CONTEXT Most antidiabetic agents target only 1 of several underlying causes of diabetes. The complementary actions of the… 
Review
1998
Review
1998
Functional food science and defence against reactive oxidative species
Abstract This paper assesses critically the science base that underpins the argument that oxidative damage is a significant… 
Highly Cited
1998
Highly Cited
1998
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
BACKGROUND Donepezil hydrochloride (Aricept) is a selective acetylcholinesterase inhibitor developed for the treatment of… 
Highly Cited
1996
Highly Cited
1996
The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
This study evaluated the efficacy and safety of donepezil in patients with mild to moderately severe Alzheimer''s disease, and… 
Highly Cited
1996
Highly Cited
1996
Olanzapine versus Placebo and Haloperidol
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)